(Q36663724)

15 August 2017

1 reference

title

Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes (English)

1 reference

15 August 2017

0 references

0 references

Jan G Aalders

1

1 reference

PubMed ID

17126892

15 August 2017

Gillian Thomas

series ordinal

2

1 reference

PubMed ID

17126892

15 August 2017

language of work or name

English

0 references

publication date

28 November 2006

1 reference

15 August 2017

1 reference

15 August 2017

104

1 reference

15 August 2017

1

1 reference

15 August 2017

222-231

1 reference

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Outcome of endometrial carcinoma patients with involvement of the uterine serosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Predictors of final histology in patients with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Surgical staging for patients presenting with grade 1 endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

An Analysis of Approaches to the Management of Endometrial Cancer in North America: A CTF Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Endometrial carcinoma: paraaortic dissemination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Surgery without radiotherapy for primary treatment of endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Survival after relapse in patients with endometrial cancer: results from a randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Endometrial carcinoma--relative effectiveness of adjuvant irradiation vs therapy reserved for relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

The salvage of recurrent endometrial carcinoma in the vagina and pelvis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Recurrent stage I endometrial carcinoma: results of treatment and prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Radiation therapy for endometrial cancer in patients treated for postoperative recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Results of Radical Radiotherapy for Recurrent Endometrial Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Recurrent endometrial adenocarcinoma after surgery alone: prognostic factors and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Stage IIIC endometrioid corpus cancer includes distinct subgroups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Surgical staging and high dose rate brachytherapy for endometrial cancer: limiting external radiotherapy to node-positive tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Endometrial cancer: predictors of peritoneal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Nodal distribution and its significance in FIGO stage IIIc endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

The effect of postsurgical therapy on stage III endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Assessment of prognostic factors in stage IIIA endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Stage III endometrial carcinoma. A review of 90 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Medically inoperable stage I endometrial carcinoma: a few dilemmas in radiotherapeutic management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Exclusive radiation therapy in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Radiotherapy alone for medically inoperable carcinoma of the cervix: stage IA and carcinoma in situ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.013

10.1016/J.YGYNO.2006.10.013

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17126892